
zzso is a major deterrent to achieving substantial improvements in cancer management, since most zzso drugs zzso distinguish normal and zzso zzso zzso the differential between beneficial and toxic effects of zzso zzso a major clinical objective, but therapeutic index for zzso drugs is zzso Fresh tumor and normal cells from 59 patients with acute zzso zzso zzso lymphoma, zzso cancer and zzso of unknown origin were tested for ex zzso drug sensitivity using zzso by zzso zzso Drugs tested included zzso zzso zzso zzso zzso zzso and zzso zzso index was derived from the ratio of normal and tumor cell zzso Individual patient therapeutic index varied markedly for different drugs and drug therapeutic index varied from patient to patient ranging from extremely zzso zzso through excellent zzso reflecting patient zzso zzso index for each drug was consistent with clinical zzso zzso there was no relationship between normal and tumor cell zzso We conclude that further laboratory and clinical evaluation is required but the derived ex zzso therapeutic index could enhance choice of chemotherapy by reducing toxicity and/or improving zzso 

